The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which expanded its focus to conduct research into COVID-19, today announced the initiation of ACTIV-2d, a global, phase 3, multicenter trial ...
Aug 22, 2022
0
10
Canada's Medicago and British pharmaceutical giant GlaxoSmithKline (GSK) announced Thursday the launch of phase 2 and 3 clinical trials on a COVID-19 vaccine, one of a series of candidates being developed worldwide.
Nov 12, 2020
0
4
A combination antibody treatment for preventing COVID-19 illness in individuals who have had sustained exposure to someone with the virus is being studied by researchers at The University of Texas Health Science Center at ...
Sep 25, 2020
0
1
Access to cancer medicines is highly unequal across Europe both for new drugs in development because of uneven access to clinical trials and for currently approved drugs due to huge disparities in healthcare spending by different ...
Sep 18, 2020
0
2
Canada announced deals on Monday with US companies Novavax and Johnson & Johnson for millions doses of their experimental COVID-19 vaccines.
Aug 31, 2020
0
2
With Russia's announcement Tuesday that it had become the first country to approve a vaccine against COVID-19, here is a look at the more than two dozen other candidates currently in development.
Aug 11, 2020
0
3
A Phase III, NRG Oncology clinical trial that compared radiosurgery (SRS) or stereotactic body radiotherapy (SBRT) to the conventional radiotherapy (cEBRT) for patients with spinal metastases indicated that there was no statistically ...
Sep 17, 2019
0
2
A study published in the British Journal of Dermatology indicates that an investigational nonsteroidal topical cream (PAC-14028) may be effective for treating atopic dermatitis, one of the most common inflammatory skin diseases.
Jan 9, 2019
0
2
Bottom Line: Among women with breast cancer who received a type of chemotherapy called an anthracycline, those who had a certain genetic biomarker had a significantly increased risk for having anthracycline-induced congestive ...
Dec 19, 2016
0
0
Adding the investigational anticancer therapeutic tivantinib to standard erlotinib treatment substantially increased progression-free survival for patients with advanced nonsquamous non–small cell lung cancer (NSCLC) who ...
Nov 9, 2015
0
9
